« Back to the previous page

Also available in:

Business case M&A deal chemicals Netherlands and Belgium

Acquisition of Isobionics BV (Seller DSM) by Tailwind Business Solutions BVBA. M&A deal in the Biotech and Lifesciences industry. Cross border deal Netherlands Belgium

Reason for Sale: Strategic Partnership
Location: Geleen (Netherlands)

Deal Overview

Isobionics BV is a company that had it's origin in DSM. DSM decided to sell this company as it could grow faster in cooperation with an external partner. Isobionics is a new company that develops and produces flavours and fragrances. Corporate Finance in Europe acted as advisor for Tailwind Business Solutions BVBA in this M&A transaction in the Netherlands.

Investment Highlights

  • Large potential
  • New differentiating technology
  • Fast growing
  • Extending local reach to international

About Corporate Finance in Europe

Corporate Finance in Europe is an European M&A firm that provides corporate finance services to European companies. Corporate Finance in Europe is mainly active in European cross border M&A transactions. Corporate Finance in Europe assists European business owners sell their companies to international buyers to offer them the best deal possible. Thanks to our team's background we are able to find the most suitable acquirers in Europe as well as in the USA.

Contact us for more information about this m&a transaction. Visit m&a in chemicals for more information about the chemical industry